1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,820 | 5,150 | 15:00 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.11.25 | Tigermed Selected as "2025 Forbes China Go-International Flagship Brands" Top 30 | 300 | PR Newswire | HANGZHOU, China, Nov. 6, 2025 /PRNewswire/ -- Tigermed has been selected as one of the Top 30 companies on the "2025 Forbes China Go-International Flagship Brands" list, Forbes China... ► Artikel lesen | |
| 28.10.25 | Hangzhou Tigermed Consulting Co Ltd Profit Advances In Nine Months | 1 | RTTNews | ||
| 28.10.25 | TIGERMED (03347): 2025 THIRD QUARTERLY REPORT | 1 | HKEx | ||
| 16.10.25 | TIGERMED (03347): DATE OF BOARD MEETING | - | HKEx | ||
| 14.10.25 | Goldman Sachs initiates Hangzhou Tigermed stock with Buy rating | 2 | Investing.com | ||
| 10.10.25 | TIGERMED (03347): VOLUNTARY ANNOUNCEMENT - DISPOSAL OF THE TARGET GROUP | 1 | HKEx | ||
| HANGZHOU TIGERMED CONSULTING Aktie jetzt für 0€ handeln | |||||
| 29.09.25 | TIGERMED (03347): ARTICLES OF ASSOCIATION | - | HKEx | ||
| 29.09.25 | TIGERMED (03347): POLL VOTING RESULTS OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING HELD ON SEPTEMBER 29, 2025 | 2 | HKEx | ||
| 25.09.25 | TIGERMED (03347): 2025 INTERIM REPORT | - | HKEx | ||
| 08.09.25 | TIGERMED (03347): FORM OF PROXY FOR THE 2025 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON MONDAY, SEPTEMBER 29, 2025 | 3 | HKEx | ||
| 08.09.25 | TIGERMED (03347): NOTICE OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING | 1 | HKEx | ||
| 08.09.25 | TIGERMED (03347): 2025 FIRST EGM CIRCULAR | - | HKEx | ||
| 28.08.25 | TIGERMED (03347): TERMS OF REFERENCE OF THE STRATEGY DEVELOPMENT COMMITTEE OF THE BOARD OF DIRECTORS | 1 | HKEx | ||
| 28.08.25 | TIGERMED (03347): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE OF THE BOARD OF DIRECTORS | 4 | HKEx | ||
| 28.08.25 | TIGERMED (03347): TERMS OF REFERENCE OF THE REMUNERATION AND EVALUATION COMMITTEE OF THE BOARD OF DIRECTORS | 1 | HKEx | ||
| 28.08.25 | TIGERMED (03347): TERMS OF REFERENCE OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS | 3 | HKEx | ||
| 28.08.25 | TIGERMED (03347): ELECTION OF EMPLOYEE DIRECTOR TO THE FIFTH SESSION OF THE BOARD | 2 | HKEx | ||
| 28.08.25 | TIGERMED (03347): PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND PROPOSED CERTAIN AMENDMENTS TO THE CORPORATE GOVERNANCE RULES | - | HKEx | ||
| 28.08.25 | TIGERMED (03347): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 | 2 | HKEx | ||
| 19.08.25 | Tigermed Receives MSCI ESG AAA Rating | 649 | PR Newswire | HANGZHOU, China, Aug. 19, 2025 /PRNewswire/ -- Tigermed is proud to announce that it has been awarded an MSCI Environmental, Social, and Governance (ESG) Rating of AAA, the highest rating... ► Artikel lesen |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 48,020 | -1,96 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 39,500 | -1,25 % | Carl Zeiss Meditec-Aktie sorgt für Hochspannung: Experten sehen mögliches Momentum - sofort informieren! | ||
| DRAEGERWERK | 69,10 | -0,43 % | EQS-News: Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener Aktien - Abschlussmeldung | EQS-News: Drägerwerk AG & Co. KGaA
/ Schlagwort(e): Sonstiges
Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener... ► Artikel lesen | |
| MEDTRONIC | 82,02 | +0,05 % | Bearish Options Activity Emerges on Medtronic plc (MDT) Despite Long-Term Growth Outlook | ||
| INTUITIVE SURGICAL | 481,75 | +0,48 % | Where Will Intuitive Surgical Be in 5 Years? | ||
| THERMO FISHER | 508,90 | +0,63 % | BofA Raises Thermo Fisher (TMO) Target as Biopharma Recovery Comes Into View | ||
| TELADOC HEALTH | 6,129 | +1,93 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Financial Officer Transition | NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced that Mala Murthy will be stepping down from her role as Chief Financial... ► Artikel lesen | |
| ROKU | 95,37 | +2,80 % | Wells Fargo bestätigt "Overweight"-Rating für Roku und prognostiziert starkes Wachstum bis 2026 | ||
| HIMS & HERS HEALTH | 29,050 | +1,82 % | HIMS Stock On A Losing Spree: Here's Why | ||
| SERNOVA BIOTHERAPEUTICS | 0,076 | -1,30 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| BECTON DICKINSON | 167,20 | +0,48 % | BD reports Phasix hernia mesh clinical trial milestone | ||
| BRIGHTSPRING HEALTH SERVICES | 38,400 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| GENEDX | 132,30 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROGYNY | 25,740 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,225 | 0,00 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen |
HANGZHOU TIGERMED CONSULTING CO LTD gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +7,14 % bei einem Aktienkurs von 4,800 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HANGZHOU TIGERMED CONSULTING CO LTD finden Sie auf Wallstreet Online.